See also this year's filing and all EDGAR filings for this company.
PDF Report 0001420565_2022_Rein_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001420565, Rein Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 48,177,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 128,000 |
| 3 | remainder_Assets | 176,000 |
| 4 | LiabilitiesCurrent | 4,508,000 |
| 5 | LiabilitiesNoncurrent | 69,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,740,881 |
| 9 | ResearchAndDevelopmentExpense | 17,587,849 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -522,575 |
| 13 | remainder_ComprehensiveNetIncome | -10,341 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 48,481,000 |
| 1 | Liabilities | 4,577,000 |
| 2 | Expenses | 27,328,730 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 43,904,000 |
| 5 | NetIncome | -27,851,305 |
| 6 | ComprehensiveNetIncome | -27,856,476 |
| 7 | BaseVar | 40,459,823 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.56 |
| 9 | EconomicCapitalRatio | 3.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
